Rockefeller Capital Management
LGND icon

Rockefeller Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

Rockefeller Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179K Sell
566
-42
-7% -$9.9K ﹤0.01% 2662
2026
Q1 		$121K Sell
608
-119
-16% -$23.5K ﹤0.01% 2762
2025
Q4 		$137K Sell
727
-14
-2% -$2.69K ﹤0.01% 2554
2025
Q3 		$131K Buy
+741
New +$110K ﹤0.01% 2438
2023
Q1 		– Sell
-572
Closed -$38K – 3054
2022
Q4 		$38K Sell
572
-345
-38% -$22.4K ﹤0.01% 2514
2022
Q3 		$49K Buy
917
+558
+155% +$32.8K ﹤0.01% 2355
2022
Q2 		$19K Hold
359
– – ﹤0.01% 2777
2022
Q1 		$25K Sell
359
-119
-25% -$8.63K ﹤0.01% 2623
2021
Q4 		$46K Buy
478
+157
+49% +$14.5K ﹤0.01% 2259
2021
Q3 		$27K Sell
321
-113
-26% -$8.74K ﹤0.01% 2455
2021
Q2 		$35K Hold
434
– – ﹤0.01% 2238
2021
Q1 		$40K Hold
434
– – ﹤0.01% 1982
2020
Q4 		$26K Buy
434
+121
+39% +$6.9K ﹤0.01% 1902
2020
Q3 		$17K Buy
313
+162
+107% +$11.1K ﹤0.01% 1849
2020
Q2 		$11K Sell
151
-53
-26% -$3.36K ﹤0.01% 1863
2020
Q1 		$9K Buy
204
+188
+1,175% +$10.7K ﹤0.01% 1775
2019
Q4 		$1K Buy
+16
New +$1.07K ﹤0.01% 1986
2019
Q2 		– Sell
-341
Closed -$27K – 1825
2019
Q1 		$27K Buy
341
+254
+292% +$19.2K ﹤0.01% 1124
2018
Q4 		$7K Hold
87
– – ﹤0.01% 760
2018
Q3 		$15K Hold
87
– – ﹤0.01% 534
2018
Q2 		$11K Buy
+87
New +$9.71K ﹤0.01% 586

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rockefeller Capital Management's LGND Position: Q2 2026 in Review

Rockefeller Capital Management reduced its Ligand Pharmaceuticals (LGND) stake by 6.9% in Q2 2026, selling an estimated $9.9K and leaving 566 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #2662.

Rockefeller Capital Management first reported a position in LGND in Q2 2018 and has held it in 21 quarters since. 416 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Rockefeller Capital Management held 566 shares of Ligand Pharmaceuticals worth $179K as of Q2 2026.
  • Rockefeller Capital Management sold 42 Ligand Pharmaceuticals shares in Q2 2026, an estimated $9.9K.
  • Ligand Pharmaceuticals made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #2662 holding.
  • Rockefeller Capital Management first reported a position in Ligand Pharmaceuticals in Q2 2018 and has held it in 21 quarters since.
  • 416 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.